Current status:
Cancelled Post Market
Current status date:
2005-04-26
DIN:
00391077
Electronic product monograph is not available
Company:
ICN CANADA LTD.
1956 Bourdon Street
Montreal
Quebec
Canada
H4M 1V1
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS):
See footnote 3
28:24.08
,
12:08.08
Anatomical Therapeutic Chemical (ATC):
See footnote 4
A03CA02 CLIDINIUM AND PSYCHOLEPTICS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
CHLORDIAZEPOXIDE HYDROCHLORIDE
|
5 MG / CAP
|
CLIDINIUM BROMIDE
|
2.5 MG / CAP
|